Charles River Laboratories CRL EBITDA margin
EBITDA margin at other companies
Other financials
Where this comes from
Calculated from Charles River Laboratories’s reported figures.
Based on trailing twelve months.
The official record: Charles River Laboratories’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Charles River Laboratories's ebitda margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Charles River Laboratories's EBITDA margin?
- Charles River Laboratories (CRL) reported EBITDA margin of 17.5% in Q1 2026.
- How has Charles River Laboratories's EBITDA margin changed year-over-year?
- Charles River Laboratories's EBITDA margin decreased by 11.4% year-over-year, from 19.7% to 17.5%.
- What is the long-term trend for Charles River Laboratories's EBITDA margin?
- Over 5 years (2020 to 2025), Charles River Laboratories's EBITDA margin has grown at a -5.0% compound annual growth rate (CAGR), from 22.8% to 17.7%.
- What does EBITDA margin mean?
- Operating cash profitability per sales dollar, before interest, taxes, and non-cash charges.
- How do you interpret EBITDA margin?
- Useful for comparing operating profitability across firms with different depreciation policies and leverage. High EBITDA margin alongside heavy capex can still mean weak free cash flow — pair it with FCF margin.
- How does EBITDA margin compare across companies?
- Widely used to compare capital-intensive businesses on a like-for-like basis. Less meaningful for banks and insurers.